https://www.selleckchem.com/products/r428.html
Objective To evaluate the results of excimer laser ablation (ELA) in the treatment of lower limb atherosclerotic obliterans (ASO). Methods From June 2019 to March 2020, patients who underwent ELA combined with drug-coated balloon (DC for lower limb atherosclerotic obliterans (ASO) were enrolled. Demographics, lesion characteristics, procedure-related outcomes and complications were collected and analyzed. Results Thirty patients were enrolled, including 21 males and 9 females. The mean age was (76.5±10.5) years. The mean lesion length wa
Like
Comment
Share
